TY - JOUR
T1 - A critical review of “uterine leiomyoma” with subsequent recurrence or metastasis
T2 - A multicenter study of 62 cases
AU - Sanada, Sakiko
AU - Ushijima, Kimio
AU - Yanai, Hiroyuki
AU - Mikami, Yoshiki
AU - Ohishi, Yoshihiro
AU - Kobayashi, Hiroaki
AU - Tashiro, Hironori
AU - Mikami, Mikio
AU - Miyamoto, Shingo
AU - Katabuchi, Hidetaka
N1 - Publisher Copyright:
© 2022 Japan Society of Obstetrics and Gynecology.
PY - 2022
Y1 - 2022
N2 - Aim: Histopathologic diagnosis of a subset of uterine smooth muscle tumors is challenging. We report a critical review regarding the clinicopathological point of view of 62 cases of subsequently recurred or metastasized leiomyoma. Methods: Medical records and glass slides of 62 cases of uterine smooth muscle tumor diagnosed as leiomyoma, which subsequently recurred or metastasized, were critically reviewed by pathologists specializing in gynecologic pathology and oncology. Results: In 47 (75.8%) of 62 cases, the diagnosis of leiomyoma was confirmed, including 11 intravascular leiomyomatosis (IVL) and benign metastasizing leiomyoma (BML). In 29 cases (46.8%) laparoscopic surgery was performed, of which morcellator without a bag was employed in 23 cases. Fifteen cases (24.2%) appeared to be underestimated and were re-classified as smooth muscle tumor of uncertain malignant potential (STUMP), leiomyosarcoma, or other malignant mesenchymal tumors. Recurrences in seven cases (11.3%) were interpreted to be a malignant transformation, and one STUMP recurred as STUMP. Conclusion: The recurrence or metastasis in cases of “leiomyoma” is attributed to iatrogenic or under-evaluation of primary tumors, although a subset of cases is a rare example of biological progression.
AB - Aim: Histopathologic diagnosis of a subset of uterine smooth muscle tumors is challenging. We report a critical review regarding the clinicopathological point of view of 62 cases of subsequently recurred or metastasized leiomyoma. Methods: Medical records and glass slides of 62 cases of uterine smooth muscle tumor diagnosed as leiomyoma, which subsequently recurred or metastasized, were critically reviewed by pathologists specializing in gynecologic pathology and oncology. Results: In 47 (75.8%) of 62 cases, the diagnosis of leiomyoma was confirmed, including 11 intravascular leiomyomatosis (IVL) and benign metastasizing leiomyoma (BML). In 29 cases (46.8%) laparoscopic surgery was performed, of which morcellator without a bag was employed in 23 cases. Fifteen cases (24.2%) appeared to be underestimated and were re-classified as smooth muscle tumor of uncertain malignant potential (STUMP), leiomyosarcoma, or other malignant mesenchymal tumors. Recurrences in seven cases (11.3%) were interpreted to be a malignant transformation, and one STUMP recurred as STUMP. Conclusion: The recurrence or metastasis in cases of “leiomyoma” is attributed to iatrogenic or under-evaluation of primary tumors, although a subset of cases is a rare example of biological progression.
KW - leiomyoma of the uterus/adenomyosis
KW - sarcoma/mesenchymal tumors of the uterus
KW - surgery in GYN cancers
UR - http://www.scopus.com/inward/record.url?scp=85138192745&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85138192745&partnerID=8YFLogxK
U2 - 10.1111/jog.15426
DO - 10.1111/jog.15426
M3 - Article
C2 - 36114691
AN - SCOPUS:85138192745
SN - 1341-8076
JO - Journal of Obstetrics and Gynaecology Research
JF - Journal of Obstetrics and Gynaecology Research
ER -